BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34310064)

  • 21. Stereotactic radiosurgery for recurrent vestibular schwannoma after previous resection.
    Huang MJ; Kano H; Mousavi SH; Niranjan A; Monaco EA; Arai Y; Flickinger JC; Lunsford LD
    J Neurosurg; 2017 May; 126(5):1506-1513. PubMed ID: 27471891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
    Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
    J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery ensures an effective and safe long-term control of Koos grade IV vestibular schwannomas: a single-center, retrospective, cohort study.
    Umekawa M; Shinya Y; Hasegawa H; Kawashima M; Shin M; Katano A; Minamitani M; Kashio A; Kondo K; Saito N
    J Neurooncol; 2022 Aug; 159(1):201-209. PubMed ID: 35729368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acoustic Neuroma Treated with Stereotactic Radiosurgery: Follow-up of 335 Patients.
    Rueß D; Pöhlmann L; Hellerbach A; Hamisch C; Hoevels M; Treuer H; Grau S; Jablonska K; Kocher M; Ruge MI
    World Neurosurg; 2018 Aug; 116():e194-e202. PubMed ID: 29715569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a systematic review and meta-analysis.
    Szymoniuk M; Kochański M; Wilk K; Miazga D; Kanonik O; Dryla A; Kamieniak P
    Acta Neurochir (Wien); 2024 Feb; 166(1):101. PubMed ID: 38393397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.
    Patel MA; Marciscano AE; Hu C; Jusué-Torres I; Garg R; Rashid A; Francis HW; Lim M; Redmond KJ; Rigamonti D; Kleinberg LR
    Front Oncol; 2017; 7():200. PubMed ID: 28929084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related Schwannomatosis.
    Shrivastava M; Emmanouil B; Mathew R; Halliday D; Parry A; Halliday J; Mackeith S
    Laryngoscope; 2024 May; 134(5):2364-2371. PubMed ID: 37983868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisession stereotactic radiosurgery for large vestibular schwannomas.
    Casentini L; Fornezza U; Perini Z; Perissinotto E; Colombo F
    J Neurosurg; 2015 Apr; 122(4):818-24. PubMed ID: 25594321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CyberKnife therapy for vestibular schwannoma on hearing: a retrospective study.
    Çakır O; Berkiten G; Tutar B; Yılmazer AB; Kumral TL; Saltürk Z; Uyar Y
    J Laryngol Otol; 2018 Sep; 132(9):796-801. PubMed ID: 30180915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and comorbidities of hypofractionated and single-dose radiosurgery for vestibular schwannomas: a systematic review and meta-analysis.
    Tosi U; Guadix S; An A; Wright D; Christos PJ; Pannullo S; Brandmaier A; Knisely JPS; Stieg PE; Ramakrishna R
    Neurooncol Pract; 2021 Aug; 8(4):391-404. PubMed ID: 34277018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term results of primary radiosurgery for vestibular schwannomas.
    Johnson S; Kano H; Faramand A; Pease M; Nakamura A; Hassib M; Spencer D; Sisterson N; Faraji AH; Arai Y; Monaco E; Niranjan A; Flickinger JC; Lunsford LD
    J Neurooncol; 2019 Nov; 145(2):247-255. PubMed ID: 31535315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CyberKnife Stereotactic Radiosurgery for Growing Vestibular Schwannoma: Longitudinal Tumor Control, Hearing Outcomes, and Predicting Post-Treatment Hearing Status.
    Hildrew DM; Perez PL; Mady LJ; Li J; Nilsen ML; Hirsch BE
    Laryngoscope; 2024 Jan; 134 Suppl 1():S1-S12. PubMed ID: 37178050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
    Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
    J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CyberKnife radiosurgery for acoustic neuromas: Tumor control and clinical outcomes.
    Przybylowski CJ; Baranoski JF; Paisan GM; Chapple KM; Meeusen AJ; Sorensen S; Almefty KK; Porter RW
    J Clin Neurosci; 2019 May; 63():72-76. PubMed ID: 30770165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.